In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2'')-Id gene

Diagnostic Microbiology and Infectious Disease

Volumn 37, Issue 4, 2000, Pages 297-299

  Kak, Vivek ^a   You, Il ^a   Zervos, Marcus J ^b   Kariyama, Reiko ^c   Kumon, Hiromi ^c   Chow, Joseph W ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; DIBEKACIN; GENTAMICIN; HABEKACIN; KANAMYCIN; NETILMICIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; DRUG POTENTIATION; ENTEROCOCCUS FAECIUM; ENZYME ACTIVITY; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

AMINOGLYCOSIDES; AMPICILLIN; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DIBEKACIN; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECIUM; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMERASE CHAIN REACTION; STREPTOMYCIN; VANCOMYCIN;

EID: 0034253897     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(00)00155-3     Document Type: Article

References (16)

1. Carlier C., Courvalin P. Emergence of 4′,4"-aminoglycoside nucleotidyltransferase in enterococci. Antimicrob Agents Chemother. 34:1990;1565-1569.
2. Chow J.W., Donabedian S.M., Clewell D.B., Sahm D.F., Zervos M.J. In vitro susceptibility and molecular analysis of gentamicin-resistant enterococci. Diagn Microbiol Infect Dis. 32:1998;141-146.
3. Ferretti J.J., Gilmore K.S., Courvalin P. Nucleotide sequence analysis of the gene specifying the bifunctional 6′-amino glycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J Bacteriol. 167:1986;631-638.
4. Foulds G. Pharmacokinetics of sulbactam/ampicillin in humans a review . Rev Infect Dis. 8:(Suppl. 5):1986;S503-S511.
5. Hotta K., Zhu C.B., Ogata T., Sunada A., Ishikawa J., Mizuno S. Enzymatic 2′-N-acetylation of arbekacin and antibiotic activity of its product. J Antibiotics. 49:1996;458-464.
6. Kariyama R., Kumon H., Chow L., Zervos M.J., Takata T., Tabata M., Chow J.W. In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci. J Antimicrob Chemother. 42:1998;836-838.
7. Knapp, C., & Moody, J. A. (1992). Tests to assess bactericidal activity. Clinical Microbiology Procedures Handbook, vol. 1. In H. D. Isenberg (Ed.), Washington, DC: American Society for Microbiology: pp 5.16.21-5.16.29).
8. Kondo S., Tamura A., Gomi S., Ikeda Y., Takeuchi T., Mitsuhashi S. Structures of enzymatically modified products of arbekacin by methicillin-resistant Staphylococcus aureus. J Antibiotics. 46:1993;310-315.
9. National Committee for Clinical Laboratory Standards (NCCLS). (1999). Approved Standard M7-A5: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, (5th ed.) Villanova, PA:NCCLS.
10. Osakabe Y., Takahashi Y., Narihara K. The utility and dosage and administration of arbekacin in patients with MRSA infection. Antibiotics Chemother. 12:1996;120-127.
11. Physicians' Desk Reference. (1998). (52nd ed.) Montvale NJ: Medical Economics Company, p 2210.
12. Thal L.A., Chow J.W., Patterson J.E., Perri M.B., Donabedian S., Clewell D.B., Zervos M.J. Molecular characterization of highly gentamicin-resistant Enterococcus faecalis isolates lacking high-level streptomycin resistance. Antimicrob Agents Chemother. 37:1993;134-137.
13. Trieu-Cuot P., Courvalin P. Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3′5"-aminoglycoside phosphotransferase type III. Gene. 23:1983;331-341.
14. Tsai, S. F., Zervos, M. J., Clewell, D. B., Donabedian, S. M., Sahm, D. F., Chow, J. W. (1998). A new high-level gentamicin resistance gene. aph(2")-Id, in Enterococcus sp Antimicrob Agents Chemother, 42, 1229-1232.
15. Yamamoto T., Koyama M., Nakagawa K. Phase-one clinical study on habekacin. Chemotherapy. 34:(Suppl.1):1986;S104-S116.
16. You I., Kariyama R., Zervos M.J., Kumon H., Chow J.W. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis. 36:2000;37-41.